Genenta Science (GNTA) CFO details option grants and share holdings in Form 3
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Genenta Science S.p.A. Chief Financial Officer Richard B. Slansky filed an initial ownership report showing a mix of stock options, ordinary shares and American Depositary Shares. He holds several option grants over ADSs with exercise prices of $4.76, $3.08, $4.36 and $1.48, vesting over multi‑year schedules and expiring between 2032 and 2035. In addition, he directly owns 19,947 ordinary shares and 2,200 ADSs, with each ADS representing one ordinary share.
Positive
- None.
Negative
- None.
Insider Trade Summary
8 transactions reported
Mixed
8 txns
Insider
SLANSKY RICHARD B
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | American Depositary Shares ("ADSs") | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 127,520 shares (Direct);
Ordinary Shares — 19,947 shares (Direct);
American Depositary Shares ("ADSs") — 2,200 shares (Direct)
Footnotes (1)
- Each American Depositary Share represents one ordinary share, no par value, of the Issuer. The stock options vest in two parts: options on 22,884 shares vested immediately and became exercisable on July 21, 2022; and options on 104,636 shares vest in equal monthly installments over three-years beginning July 21, 2022. The options vest in equal monthly installments over three-years beginning July 1, 2024. The stock options vest in equal monthly installments over three-years beginning June 4, 2025. The stock options were issued in place of a cash bonus for 2023 and became fully vested and exercisable on June 4, 2025. The stock options were issued in place of a cash bonus for 2024 and became fully vested and exercisable on June 4, 2025. The stock options vest in equal monthly installments over three-years beginning December 18, 2025.
